Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020031 · ClinicalTrials.gov registry record · Phase 2
Regional Prophylactic Vancomycin in Revision Total Knee Replacement
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT02020031: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT02020031 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020031, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (the knee joint) is more effective at preventing infection than the current standard dose which is given intravenously (IV) through a wrist vein.
Interventions
- DRUG Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02020031
The ClinicalTrials.gov registry entry for NCT02020031 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vancomycin is the first listed.
NCT02020031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02020031 about?
NCT02020031 is a clinical study titled "Regional Prophylactic Vancomycin in Revision Total Knee Replacement". The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (the knee joint) is more effective at preventing infection than the current standard dose which is given intravenously (IV) through a wrist vein.
What is the current status of trial NCT02020031?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2013-12. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02020031?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT02020031?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.